2011
DOI: 10.1016/j.nutres.2011.09.018
|View full text |Cite
|
Sign up to set email alerts
|

Menhaden oil administration to dogs treated with radiation for nasal tumors demonstrates lower levels of tissue eicosanoids

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 24 publications
0
2
0
Order By: Relevance
“…Many in vitro studies have been conducted and provide evidence that fatty acids such as docosahexaenoic acid and eicosapentaenoic acid are effective in reducing cancer cell viability through a variety of mechanisms in human cell lines [19][20][21][22][23] ; however, only one in vitro study has been conducted in canine cell lines. 24 One in vivo study investigated supplementation of menhaden oil in dogs with nasal carcinoma and found it may alleviate inflammatory side effects of radiation therapy 25 while another found n-3 PUFA supplementation increased disease-free interval and survival time in dogs with lymphoma; however, arginine was also supplemented in this T A B L E 5 Time spent researching pet health topics, pet nutrition and nutritional supplements, proportion of pet owners feeding nutritional supplements and number of supplements fed per dog in dogs with cancer and healthy dogs from an online dog owner survey regarding diet and supplement use Note: N, number of respondents; %, proportion; IQR, inter-quartile range reported as the range from Q1 to Q3; min, minimum; max, maximum. Significant (Mann-Whitney U test, P < .05) differences between dogs with cancer and healthy dogs are indicated by P values.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Many in vitro studies have been conducted and provide evidence that fatty acids such as docosahexaenoic acid and eicosapentaenoic acid are effective in reducing cancer cell viability through a variety of mechanisms in human cell lines [19][20][21][22][23] ; however, only one in vitro study has been conducted in canine cell lines. 24 One in vivo study investigated supplementation of menhaden oil in dogs with nasal carcinoma and found it may alleviate inflammatory side effects of radiation therapy 25 while another found n-3 PUFA supplementation increased disease-free interval and survival time in dogs with lymphoma; however, arginine was also supplemented in this T A B L E 5 Time spent researching pet health topics, pet nutrition and nutritional supplements, proportion of pet owners feeding nutritional supplements and number of supplements fed per dog in dogs with cancer and healthy dogs from an online dog owner survey regarding diet and supplement use Note: N, number of respondents; %, proportion; IQR, inter-quartile range reported as the range from Q1 to Q3; min, minimum; max, maximum. Significant (Mann-Whitney U test, P < .05) differences between dogs with cancer and healthy dogs are indicated by P values.…”
Section: Discussionmentioning
confidence: 99%
“…Many in vitro studies have been conducted and provide evidence that fatty acids such as docosahexaenoic acid and eicosapentaenoic acid are effective in reducing cancer cell viability through a variety of mechanisms in human cell lines 19‐23 ; however, only one in vitro study has been conducted in canine cell lines 24 . One in vivo study investigated supplementation of menhaden oil in dogs with nasal carcinoma and found it may alleviate inflammatory side effects of radiation therapy 25 while another found n‐3 PUFA supplementation increased disease‐free interval and survival time in dogs with lymphoma; however, arginine was also supplemented in this group and lymphoma staging was based on subjective methodology, both of which greatly limits interpretation of the results 26 . Since n‐3 FA supplements have also been previously reported at a high frequency among healthy animals, it is possible that other conditions, such as those impacted by aging, may be confounding reasons to administer these and other supplements that were highly reported among the dogs with cancer.…”
Section: Discussionmentioning
confidence: 99%